Ashley Nilson, Phd
AeroLeads people directory · profile

Ashley Nilson, Phd Email & Phone Number

Scientist - Receptor Pharmacology at MapLight Therapeutics, Inc.
Location: San Francisco Bay Area, United States 4 work roles 2 schools
1 work email found @nih.gov LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email a****@nih.gov
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
MapLight Therapeutics, Inc.
Role
Scientist - Receptor Pharmacology
Location
San Francisco Bay Area, United States
Company size
19 employees

Who is Ashley Nilson, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ashley Nilson, Phd is listed as Scientist - Receptor Pharmacology at MapLight Therapeutics, Inc., a with 19 employees, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at nih.gov and a matched LinkedIn profile for Ashley Nilson, Phd.

Ashley Nilson, Phd previously worked as Postdoctoral Researcher at National Institute Of Neurological Disorders And Stroke (Ninds) and Graduate Research Assistant at The University Of Texas Medical Branch At Galveston. Ashley Nilson, Phd holds Doctor Of Philosophy (Phd), Neuroscience, 3.97 from The University Of Texas Medical Branch At Galveston.

Company email context

Email format at MapLight Therapeutics, Inc.

This section adds company-level context without repeating Ashley Nilson, Phd's masked contact details.

*@nih.gov
68% confidence

AeroLeads found 1 current-domain work email signal for Ashley Nilson, Phd. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Ashley Nilson, Phd

My career aspirations are to improve people's lives through making better medicines to treat devastating diseases. To do this, I aim to discover novel drugs and develop them into novel treatments. As a molecular pharmacologist, I am well suited for target discovery, validation, and compound optimization during early stage drug development.I have rigorous training in mechanism-of-action studies, structure activity relationships, and working collaboratively to select lead candidates based upon define criteria.I'm a detail oriented and excellent collaborator using in vitro techniques to determine affinity, potency, efficacy, and receptor trafficking that contributed to 7+ significant projects on the dopamine D1 through D5 receptors as well as 5HT2A and orphan receptors. I am well versed in GPCR ligands and current trends including agonist, antagonists, PAMs, NAMs, and functional selectivity.I have the ability to communicate to a wide array of audiences both public and scientific. This has led to multiple awards and invited talks through scientific conferences and in the community. Throughout my career, I continue to engage with family members and the public about science and how I am working to improve health through new medications.Outside of my work, I am always finding new activities to enrich myself including sewing, reading, and baking.

Listed skills include Western Blotting, Immunofluorescence, Cell Culture, Primary Neuron Culture, and 17 others.

Current workplace

Ashley Nilson, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

MapLight Therapeutics, Inc.
Maplight Therapeutics, Inc.
Scientist - Receptor Pharmacology
palo alto, california, united states
Website
maplightrx.com
Employees
19
AeroLeads page
Company profile
View company profile Email format
4 roles

Ashley Nilson, Phd work experience

A career timeline built from the work history available for this profile.

Scientist - Receptor Pharmacology

Current
Maplight Therapeutics, Inc.

United States

GPCR pharmacology with a focus on Neurological disorders.

Sep 2024 - Present

Postdoctoral Researcher

National Institute Of Neurological Disorders And Stroke (Ninds)

Bethesda, Maryland, United States

Pharmacology lead for several SAR projects surrounding the dopamine D1, D2, and D4 receptors. I am working on a variety of ligands including agonists, antagonists, and PAMs. The main goals of these projects are to optimize affinity, function, and metabolic stability to develop lead candidates for therapeutic development.Assays used include competition and saturation radioligand binding assays, functional plate based assays (96 and 384-well formats) including b-arrestin, cAMP, and BRET. I also manage various CROs for compound synthesis, pharmacokinetic and brain penetrance, toxicology, and receptor selectivity.My projects work to advance therapeutic candidates for diseases such as schizophrenia, Parkinson's, and substance use disorders among others. In this role, I have enjoyed my time running experiments and mentoring postbaccalaureate students. In addition, I manage lab inventory and ordering for our entire group.

Sep 2020 - Sep 2024

Graduate Research Assistant

The University Of Texas Medical Branch At Galveston

Galveston

My PhD work focused on the mechanism-of-action of D1 dopamine receptor agonists. Using a variety of D1R selective ligands, I characterized their ability of stimulate cAMP production and recruit beta-arrestin. The results was an array of compounds from distinct pharmacophores, that exhibited varied levels of functional selectivity from G protein biased to no bias. I further demonstrated that the level of beta-arrestin recruitment strongly correlated to receptor endocytosis. This extended the mechanism-of-action of D1R G protein biased agonists (including the new non-catechol ligands) to include reduced endocytosis which may have implications on receptor desensitization and re-sensitization.

Aug 2014 - Aug 2020

Undergraduate Researcher

Washington State University

Pullman

I worked in a variety of labs ranging from clinical research labs to in vivo drug development. My senior project involved testing the ability of a lead drug candidate for the treatment of Parkinson's disease to penetrate the gastric barrier in addition to the blood brain barrier. I conducted all the motor behavioral testing for three cohorts of rats while being blinded to treatment condition. My results replicated a previous study that used i.p. injections indicating that our compound passes the gastric barrier and could be formulated into a pill in future development.

Aug 2011 - May 2014
Team & coworkers

Colleagues at MapLight Therapeutics, Inc.

Other employees you can reach at maplightrx.com. View company contacts for 19 employees →

RN Ryan Nelson Ryan Nelson Colleague at Maplight Therapeutics, Inc.Missoula, Montana, United States View → GC Gabriel Cisneroz Gabriel Cisneroz Colleague at Maplight Therapeutics, Inc.San Francisco Bay Area, United States View → RP Reyna Palacio Reyna Palacio Colleague at Maplight Therapeutics, Inc.Dallas-Fort Worth Metroplex, United States View → KT Kimberly Thompson Kimberly Thompson Colleague at Maplight Therapeutics, Inc.San Francisco, California, United States View → JW Jean Weustenraed Jean Weustenraed Colleague at Maplight Therapeutics, Inc.Greater Sacramento, United States View → TV Tessa Van Grack Tessa Van Grack Colleague at Maplight Therapeutics, Inc.Denver Metropolitan Area, United States View → JP Jennifer Powell Jennifer Powell Colleague at Maplight Therapeutics, Inc.Wilmington, Delaware, United States View → ER Estefania Reyes Bricio Estefania Reyes Bricio Colleague at Maplight Therapeutics, Inc.South San Francisco, California, United States View → MQ Madison Quinn Madison Quinn Colleague at Maplight Therapeutics, Inc.Charleston County, South Carolina, United States View → LL Liliane Leaser Liliane Leaser Colleague at Maplight Therapeutics, Inc.Flagstaff, Arizona, United States View →
2 education records

Ashley Nilson, Phd education

Bachelor Of Science (B.S.), Neuroscience, 3.97

Washington State University

Activities and Societies: Phi Beta KappaConducted research as an undergraduate researcher with Dr. Joseph Harding. I conducted animal.

FAQ

Frequently asked questions about Ashley Nilson, Phd

Quick answers generated from the profile data available on this page.

What company does Ashley Nilson, Phd work for?

Ashley Nilson, Phd works for MapLight Therapeutics, Inc..

What is Ashley Nilson, Phd's role at MapLight Therapeutics, Inc.?

Ashley Nilson, Phd is listed as Scientist - Receptor Pharmacology at MapLight Therapeutics, Inc..

What is Ashley Nilson, Phd's email address?

AeroLeads has found 1 work email signal at @nih.gov for Ashley Nilson, Phd at MapLight Therapeutics, Inc..

Where is Ashley Nilson, Phd based?

Ashley Nilson, Phd is based in San Francisco Bay Area, United States while working with MapLight Therapeutics, Inc..

What companies has Ashley Nilson, Phd worked for?

Ashley Nilson, Phd has worked for Maplight Therapeutics, Inc., National Institute Of Neurological Disorders And Stroke (Ninds), The University Of Texas Medical Branch At Galveston, and Washington State University.

Who are Ashley Nilson, Phd's colleagues at MapLight Therapeutics, Inc.?

Ashley Nilson, Phd's colleagues at MapLight Therapeutics, Inc. include Ryan Nelson, Gabriel Cisneroz, Reyna Palacio, Kimberly Thompson, and Jean Weustenraed.

How can I contact Ashley Nilson, Phd?

You can use AeroLeads to view verified contact signals for Ashley Nilson, Phd at MapLight Therapeutics, Inc., including work email, phone, and LinkedIn data when available.

What schools did Ashley Nilson, Phd attend?

Ashley Nilson, Phd holds Doctor Of Philosophy (Phd), Neuroscience, 3.97 from The University Of Texas Medical Branch At Galveston.

What skills is Ashley Nilson, Phd known for?

Ashley Nilson, Phd is listed with skills including Western Blotting, Immunofluorescence, Cell Culture, Primary Neuron Culture, Statistical Data Analysis, Event Planning, Educational Outreach, and Receptor Pharmacology.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.